(Q39204026)

10 September 2017

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation (English)

1 reference

10 September 2017

1 reference

diabetic cardiomyopathy

1 reference

Yang Bai

1

1 reference

10 September 2017

Wenpeng Cui

2

1 reference

10 September 2017

Ying Xin

3

1 reference

10 September 2017

Xiao Miao

4

1 reference

10 September 2017

Michelle T Barati

5

1 reference

10 September 2017

Chi Zhang

6

1 reference

10 September 2017

Qiang Chen

7

1 reference

10 September 2017

Yi Tan

8

1 reference

10 September 2017

Taixing Cui

9

1 reference

10 September 2017

Yang Zheng

10

1 reference

10 September 2017

Lu Cai

11

1 reference

10 September 2017

23 January 2013

1 reference

Journal of Molecular and Cellular Cardiology

10 September 2017

1 reference

10 September 2017

57

1 reference

10 September 2017

82-95

1 reference

Oxidative stress and diabetic cardiomyopathy: a brief review

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Nrf2 activators as attractive therapeutics for diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Protective effect of sulforaphane against oxidative stress: recent advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase C/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

The role of oxidative stress and NF-kappaB activation in late diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Oxidative stress, diabetes, and diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Diabetes-induced hepatic pathogenic damage, inflammation, oxidative stress, and insulin resistance was exacerbated in zinc deficient mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

UKPDS and the legacy effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Zinc protects endothelial cells from hydrogen peroxide via Nrf2-dependent stimulation of glutathione biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Hepatoprotection of quercetin against oxidative stress by induction of metallothionein expression through activating MAPK and PI3K pathways and enhancing Nrf2 DNA-binding activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.01.008

10.1016/J.YJMCC.2013.01.008

7 January 2021

Identifiers

DOI

1 reference

10 September 2017

1 reference